Production of recombinant proteins by autoproteolytic cleavage of a fusion protein

Details for Australian Patent Application No. 2006239723 (hide)

Owner Sandoz AG Boehringer Ingelheim RCV GmbH & Co KG

Inventors Hahn, Rainer; Kaar, Waltraud; Tscheliessnig, Anne; Jungbauer, Alois

Agent Pizzeys

Pub. Number AU-B-2006239723

PCT Pub. Number WO2006/113959

Priority 0508434.8 26.04.05 GB; 0508435.5 26.04.05 GB; 0605379.7 16.03.06 GB

Filing date 25 April 2006

Wipo publication date 2 November 2006

Acceptance publication date 22 December 2011

International Classifications

C07K 1/16 (2006.01) General processes for the preparation of peptides

C07K 1/22 (2006.01) General processes for the preparation of peptides

C12N 9/50 (2006.01) Enzymes, e.g. ligases (6.) - Proteinases

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/113959 Priority application(s): WO2006/113959

13 August 2009 Assignment before Grant

  Sandoz AG; Boehringer Ingelheim Austria GmbH The application has been assigned to Sandoz AG; Boehringer Ingelheim RCV GmbH & Co KG

22 December 2011 Application Accepted

  Published as AU-B-2006239723

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006239726-Animal models for cell therapy and cell based gene therapy

2006239722-Affinity ligands